Lördag 21 Juni | 14:02:03 Europe / Stockholm

Prenumeration

2025-05-26 11:31:00

Redeye shares its thoughts after CTEK’s capital markets day (CMD), which took place on Thursday last week. We think the CMD underpinned in detail the roadmap for each business area to reach the new group target of having SEK2bn in sales and 20% Adj. EBITA margin by 2028. We update our estimates and fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/